au.\*:("KROOG, G")
Results 1 to 6 of 6
Selection :
Vasoactive intestinal peptide increases intracellular cAMP and gonadotropin-α gene activity in JEG-3 syncytial trophoblasts : constraints posed by desensitizationDEUTSCH, P. J; YU SUN; KROOG, G. S et al.The Journal of biological chemistry (Print). 1990, Vol 265, Num 18, pp 10274-10281, issn 0021-9258, 8 p.Article
Phase I study of Paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancerHERSCHER, L. L; HAHN, S. M; KROOG, G et al.Journal of clinical oncology. 1998, Vol 16, Num 2, pp 635-641, issn 0732-183XArticle
Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinomaFIGG, W. D; KROOG, G; DURAY, P et al.Cancer. 1997, Vol 79, Num 10, pp 1964-1968, issn 0008-543XArticle
Acute arterial thrombosis in a patient with breast cancer after chemotherapy with 5-fluorouracil, doxorubicin, leucovorin, cyclophosphamide, and interleukin-3THEODOSSIOU, C; KROOG, G; ETTINGHAUSEN, S et al.Cancer. 1994, Vol 74, Num 10, pp 2808-2810, issn 0008-543XArticle
Mammalian bombesin receptorsKROOG, G. S; JENSEN, R. T; BATTEY, J. F et al.Medicinal research reviews (Print). 1995, Vol 15, Num 5, pp 389-417, issn 0198-6325Article
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancerZHONG CHEN; MALHOTRA, P. S; MCCULLAGH, L et al.Clinical cancer research. 1999, Vol 5, Num 6, pp 1369-1379, issn 1078-0432Article